KEGG IDs are linked to the KEGG website (http://www.genome.jp). The list of HD-relevant genes for each category can be found following the links provided in the Term column.
| KEGGID | P-Value | FDR | Odds Ratio | Expected Count | Count | Total number | Term |
|---|---|---|---|---|---|---|---|
| 4080 | 1.42E-18 | 2.43E-16 | 3.92 | 29.32 | 80 | 256 | Neuroactive ligand-receptor interaction |
| 4210 | 9.14E-13 | 7.82E-11 | 5.64 | 10.07 | 36 | 88 | Apoptosis |
| 5016 | 4.54E-12 | 2.59E-10 | 3.63 | 19.92 | 53 | 174 | Huntington's disease |
| 5014 | 2.83E-11 | 1.21E-09 | 7.21 | 6.29 | 26 | 55 | Amyotrophic lateral sclerosis (ALS) |
| 4020 | 3.13E-10 | 1.07E-08 | 3.26 | 20.15 | 50 | 176 | Calcium signaling pathway |
| 3010 | 1.14E-09 | 3.25E-08 | 4.63 | 9.73 | 31 | 85 | Ribosome |
| 4722 | 1.62E-09 | 3.95E-08 | 3.69 | 14.31 | 39 | 125 | Neurotrophin signaling pathway |
| 4720 | 3.32E-09 | 7.10E-08 | 5.04 | 8.01 | 27 | 70 | Long-term potentiation |
| 3050 | 1.35E-08 | 2.57E-07 | 6.64 | 5.03 | 20 | 44 | Proteasome |
| 5010 | 3.60E-08 | 6.16E-07 | 2.99 | 18.32 | 43 | 160 | Alzheimer's disease |
| 4012 | 4.15E-08 | 6.46E-07 | 4.01 | 9.96 | 29 | 87 | ErbB signaling pathway |
| 4930 | 5.38E-08 | 7.66E-07 | 5.89 | 5.38 | 20 | 47 | Type II diabetes mellitus |
| 5200 | 7.16E-08 | 8.98E-07 | 2.25 | 37.56 | 70 | 328 | Pathways in cancer |
| 5215 | 7.35E-08 | 8.98E-07 | 3.88 | 10.19 | 29 | 89 | Prostate cancer |
| 5221 | 9.62E-08 | 1.10E-06 | 5.01 | 6.52 | 22 | 57 | Acute myeloid leukemia |
| 4910 | 2.39E-07 | 2.56E-06 | 3.02 | 15.57 | 37 | 136 | Insulin signaling pathway |
| 5223 | 8.13E-07 | 8.17E-06 | 4.67 | 6.18 | 20 | 54 | Non-small cell lung cancer |
| 5210 | 1.09E-06 | 1.03E-05 | 3.58 | 9.62 | 26 | 84 | Colorectal cancer |
| 5213 | 1.95E-06 | 1.76E-05 | 4.57 | 5.95 | 19 | 52 | Endometrial cancer |
| 5212 | 2.49E-06 | 2.12E-05 | 3.73 | 8.24 | 23 | 72 | Pancreatic cancer |
| 4370 | 5.44E-06 | 4.43E-05 | 3.52 | 8.59 | 23 | 75 | VEGF signaling pathway |
| 5216 | 6.07E-06 | 4.72E-05 | 6.40 | 3.32 | 13 | 29 | Thyroid cancer |
| 4150 | 8.84E-06 | 6.57E-05 | 4.19 | 5.95 | 18 | 52 | mTOR signaling pathway |
| 4912 | 9.98E-06 | 7.11E-05 | 2.99 | 11.33 | 27 | 99 | GnRH signaling pathway |
| 4540 | 1.50E-05 | 0.000102 | 3.06 | 10.30 | 25 | 90 | Gap junction |
| 5222 | 2.05E-05 | 0.000134 | 3.08 | 9.85 | 24 | 86 | Small cell lung cancer |
| 4062 | 2.89E-05 | 0.000183 | 2.23 | 21.64 | 41 | 189 | Chemokine signaling pathway |
| 4010 | 3.57E-05 | 0.000217 | 1.98 | 30.81 | 53 | 269 | MAPK signaling pathway |
| 4510 | 5.21E-05 | 0.000306 | 2.13 | 22.90 | 42 | 200 | Focal adhesion |
| 5020 | 6.86E-05 | 0.000391 | 4.65 | 4.00 | 13 | 35 | Prion diseases |
| 4620 | 0.000103093 | 0.000568 | 2.64 | 11.45 | 25 | 100 | Toll-like receptor signaling pathway |
| 4666 | 0.000118526 | 0.000614 | 2.68 | 10.88 | 24 | 95 | Fc gamma R-mediated phagocytosis |
| 4920 | 0.000117331 | 0.000614 | 3.13 | 7.67 | 19 | 67 | Adipocytokine signaling pathway |
| 5120 | 0.000145802 | 0.000733 | 3.06 | 7.78 | 19 | 68 | Epithelial cell signaling in Helicobacter pylori infection |
| 5220 | 0.000162096 | 0.000791 | 2.93 | 8.47 | 20 | 74 | Chronic myeloid leukemia |
| 4662 | 0.000197904 | 0.000940 | 2.87 | 8.59 | 20 | 75 | B cell receptor signaling pathway |
| 5211 | 0.000221463 | 0.001023 | 2.94 | 8.01 | 19 | 70 | Renal cell carcinoma |
| 4730 | 0.000270799 | 0.001218 | 2.88 | 8.13 | 19 | 71 | Long-term depression |
| 4664 | 0.000290876 | 0.001275 | 2.77 | 8.81 | 20 | 77 | Fc epsilon RI signaling pathway |
| 4144 | 0.000364952 | 0.001560 | 2.01 | 21.07 | 37 | 184 | Endocytosis |
| 5214 | 0.000507164 | 0.002115 | 2.91 | 7.21 | 17 | 63 | Glioma |
| 5012 | 0.000552313 | 0.002248 | 2.23 | 14.08 | 27 | 123 | Parkinson's disease |
| 4310 | 0.000750976 | 0.002986 | 2.05 | 17.29 | 31 | 151 | Wnt signaling pathway |
| 4660 | 0.000920987 | 0.003579 | 2.26 | 12.37 | 24 | 108 | T cell receptor signaling pathway |
| 4270 | 0.001574869 | 0.005984 | 2.15 | 12.82 | 24 | 112 | Vascular smooth muscle contraction |
| 1063 | 0.002467529 | 0.009172 | 2.61 | 6.87 | 15 | 60 | Biosynthesis of alkaloids derived from shikimate pathway |
| 5110 | 0.002843628 | 0.010345 | 2.68 | 6.29 | 14 | 55 | Vibrio cholerae infection |
| 1062 | 0.002972209 | 0.010588 | 2.46 | 7.67 | 16 | 67 | Biosynthesis of terpenoids and steroids |
| 4070 | 0.00345029 | 0.012040 | 2.34 | 8.47 | 17 | 74 | Phosphatidylinositol signaling system |
| 380 | 0.00415394 | 0.014206 | 2.97 | 4.58 | 11 | 40 | Tryptophan metabolism |
| 1061 | 0.004793014 | 0.016070 | 2.49 | 6.64 | 14 | 58 | Biosynthesis of phenylpropanoids |
| 5218 | 0.005483501 | 0.018032 | 2.28 | 8.13 | 16 | 71 | Melanoma |
| 1066 | 0.006325703 | 0.020031 | 2.24 | 8.24 | 16 | 72 | Biosynthesis of alkaloids derived from terpenoid and polyketide |
| 5219 | 0.006221175 | 0.020031 | 2.77 | 4.81 | 11 | 42 | Bladder cancer |
| 1064 | 0.010319521 | 0.032084 | 2.23 | 7.21 | 14 | 63 | Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid |